HUABAO INTL (00336) achieved a revenue of approximately 1.878 billion yuan in the first half of the year, a year-on-year increase of 15.9%.
Hua Bao International (00336) announced its mid-term results for 2026, with revenue of approximately 1.878 billion yuan, a year-on-year increase of 15.9%; gross profit of approximately 766 million yuan, a year-on-year increase of 8.8%; profit attributable to equity holders of the company was approximately 104 million yuan, with basic and diluted earnings per share of 3.23 cents. It plans to declare an interim dividend of 1.2 Hong Kong cents per share and a special dividend of 4.08 Hong Kong cents per share.
HUABAO INTL (00336) announced its interim results for 2026, showing a turnover of approximately 1.878 billion yuan, a year-on-year increase of 15.9%; gross profit of approximately 766 million yuan, up 8.8% year-on-year; profit attributable to shareholders of the company was approximately 104 million yuan, with basic and diluted earnings per share of 3.23 cents. The company plans to distribute an interim dividend of 1.2 Hong Kong cents per share and a special dividend of 4.08 Hong Kong cents per share.
From a business segment perspective, the flavor business achieved year-on-year revenue growth, mainly due to steady sales growth from key customers, successful expansion of new customers, and an increase in the international business footprint, along with rising demand for categories such as natural flavors and flavor compounds, which contributed to effective gains; the revenue from the fragrance and personal care products business increased because Huabao Technology proactively tapped into overseas and domestic new and existing customers, achieving success in market expansion; the nutrition and health business saw significant revenue growth, mainly driven by a substantial increase in collaboration scale with key customers in the sports nutrition sector year-on-year.
Related Articles

US Stock Market Move | The MSCI index exclusion risk strikes again, and Strategy (MSTR.US) has dropped over 4%.

MP CARDIOFLOW-B(02160) has appointed Zhang Ruinian as the company's president.

KAFELAKU COFFEE (01869) released its interim results, reporting a loss attributable to shareholders of HKD 10.219 million, a year-on-year decrease of 12.09%.
US Stock Market Move | The MSCI index exclusion risk strikes again, and Strategy (MSTR.US) has dropped over 4%.

MP CARDIOFLOW-B(02160) has appointed Zhang Ruinian as the company's president.

KAFELAKU COFFEE (01869) released its interim results, reporting a loss attributable to shareholders of HKD 10.219 million, a year-on-year decrease of 12.09%.

RECOMMEND





